ABVC Biopharma Inc Capital Reinvestment Ratio

Latest as of September 2024: 0.00x

ABVC Biopharma Inc capital reinvestment ratio. ABVC Biopharma Inc (ABVC) has a Capital Reinvestment Ratio of 0.00x as of September 2024, meaning it reinvests 0% of its operating cash flow ($171.72K) in capital expenditures ($3.00). Check ABVC total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.00x
Capex / Operating Cash Flow

Operating Cash Flow

$171.72K
USD

Capital Expenditures

$3.00
USD

Data as of

Sep 2024
Most recent filing

Capital Reinvestment Ratio of ABVC Biopharma Inc (2014–2014)

Capital reinvestment ratio of ABVC Biopharma Inc from 2014 to 2014. This chart tracks ABVC Biopharma Inc's Capital Reinvestment Ratio across 1 annual periods. Also explore ABVC Biopharma Inc (ABVC) equity growth momentum to track the company's year-over-year net asset growth rate.

ABVC Biopharma Inc Capital Reinvestment Ratio by Year (2014–2014)

ABVC Biopharma Inc capital reinvestment ratio by year from 2014 to 2014. For the full cash flow conversion analysis, see cash flow conversion of ABVC Biopharma Inc.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2014 16.73x $1.17K $19.55K —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow